About the Company
Gemini Therapeutics is a clinical stage precision medicine company developing novel therapeutic compounds to treat genetically de?ned age-related macular degeneration (AMD). Gemini's lead candidate, GEM103, is a recombinant form of the human complement factor H protein (CFH), and is designed to address both complement hyperactivity and restore retinal health in patients with AMD. GEM103 is currently in a Phase 2a trial in dry AMD patients with a CFH risk variant. The company has generated a rich pipeline including recombinant proteins, gene therapies, and monoclonal antibodies.
Fundamental Data and Insider Transactions (Quarterly data) Full Screen
Loading the fundamentals chart...
Latest $GMTX News
Google Gemini finally comes to older Android devices
Gemini, Google's rebranded language model, now supports Android 10 and 11, making it accessible to more users on the go.
Intellia Therapeutics Inc NTLA
We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...
Google Gemini's conversation mode could make interactions with AI easier
Google is working on improving Gemini's response time to compete with Google Assistant on Android. Gemini could soon ...
Gemini AI is heading to older Android phones, and could get a new 'conversation' mode
Up until now, you've needed a phone running Android 12 or later to make use of the Google Gemini AI app for Android, but that ...
Seelos Therapeutics Inc SEEL
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings ...
Design Therapeutics, Inc.
Design Therapeutics, Inc. operates as a biotechnology company that develops therapies for serious degenerative disorders. It is created to design, develop and commercialize a novel class of small ...
Google Gemini on Android could soon summarize PDFs and other files — here’s what you need to know
A recent report has indicated that Google could update the Google Gemini App on Android to allow uploads of more types of ...
Outlook Therapeutics, Inc. (OTLK)
ISELIN, N.J., April 15, 2024 (GLOBE NEWSWIRE) -- Outlook Therapeutics, Inc. (Nasdaq: OTLK), a biopharmaceutical company working to achieve the first approval for an ophthalmic formulation of ...
Revance Therapeutics, Inc. (RVNC)
Revance Therapeutics, Inc. (NASDAQ:RVNC) Q4 2023 Earnings Call Transcript February 29, 2024 Revance Therapeutics, Inc. isn’t one of the 30 most popular stocks among hedge funds at the end of the ...
The Samsung S25 Series May Come With Gemini Nano 2 Onboard
Samsung doesn't plan to let up on the AI love with the S25 generation next year. The lineup should support Google's upcoming ...
Viking Therapeutics Inc (VKTX)
On Tuesday, Viking Therapeutics (NASDAQ:VKTX) saw its price target increased by an Oppenheimer analyst to $138 from the previous $116, while the stock's rating remains at... On Tuesday, Viking ...
Intellia Therapeutics, Inc.
Intellia Therapeutics, Inc. is a clinical stage genome editing company, which engages in the development of curative therapeutics using the CRISPR/Cas9 system. Its CRISPR/Cas9 system transforms ...
Loading the latest forecasts...